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ABSTRACT
STRUCTURE-ACTIVITY RELATIONSHIP MODEL FOR ESTROGEN
RECEPTOR LIGANDS
Huihui Wu
November 29,2011
Xenoestrogens are spread throughout the environment affecting our daily
lives and may produce potential toxic effects on human health. The purpose of
this study was to develop a mechanistically reliable model capable of identifying
xenoestrogens. Our hypothesis was that there are identifiable structural
characteristics among a diverse set of estrogen receptor ligands that differentiate
estrogenic and nonestrogenic compounds. The model's learning set was
developed by collecting compounds from the National Center for Toxicological
Research

Estrogen

Receptor

Binding

database

(NCTRER)

. The

categorical-SAR (cat-SAR) expert system was used to build the models and
perform leave-none-out, leave-one-out, leave-many-out and external validations
for model analysis. The values of all validations were between 0.80 and 0.97.
Based on several analyses of rational subsets of compounds included in the
NCTRER based on potency or chemical structure, it was observed that the
developed SAR models predictivity varied across sets. This indicates that
variability in the SAR models or the in vitro assay results themselves must be
considered when applying SAR models for prediction or mechanistic analyses of

v

estrogen receptor ligands. Fragment analysis was carried out to study the
mechanism of estrogen receptor binding, and various important fragments were
identified that demonstrate potential structural characteristics important for
binding. Furthermore, this led to the discovery that the cat-SAR expert system
was able to make a higher percentage of correct predictions on specific classes of
xenoestrogen expressing these key functional groups.

In conclusion, this

estrogen receptor ligand model has good predictive performance and is based on
model attributes that are mechanistically sound.
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CHAPTER I
INTRODUCTION
Estrogen is an essential hormone in many biological processes such as
sexual development, reproduction, cardiovascular and bone health. It is a steroid
hormone, and includes three naturally occurring types: estrone,
and estriol.

17~-estradiol

17~-estradiol

is the predominant form in non-pregnant females. For

medical applications, estrogen receptor agonists and antagonists can be used as
oral contraceptives,

hormone replacement therapies, and breast cancer

therapies.
Estrogen and its derivatives produce effects though the interaction with the
estrogen receptor (ER). As of now, three types of ERs have been identified: ER-a,
ER-~,

and G protein-coupled receptor 30 (GPR30) [1-4]. ER-a and

ER-~

are

classic nuclear receptors and act as ligand-activated nuclear transcription factors
that bind regulatory response elements in the promoter regions of genes [5] and
regulate gene expression. GPR30 is a seven transmembrane domain G
protein-coupled receptor (GPCR) with low homology to existing GPCRs [6] It
binds estrogen and triggers the rapid non-genomic signaling events such as
mitogen-activated protein kinase (MAPK) and Akt pathway activation [7].
Therefore, estrogens can trigger both genomic and non-genomic signaling
pathways. Also, the ERs are widely distributed throughout the body, and found in
such systems as the cardiovascular, nervous, reproductive, and musculoskeletal

[8]. The various types and locations of ERs as well as the multiple effects they
cause make them critical in human physiology and pathology.
Recent studies have shown that there are various types of chemicals found in
the environment that can mimic the action of natural estrogen. These compounds
are called endocrine disruptors (EDs), and are substances that "interfere with the
synthesis, secretion, transport, binding, action, or elimination of natural hormones
in the body that are responsible for development, behavior, fertility, and
maintenance of homeostasis (normal cell metabolism)" [9]. In 2009 The
Endocrine Society released a scientific statement outlining mechanisms and
effects of endocrine disruptors on reproduction, development, breast cancer,
prostate cancer, neuroendocrinology, thyroid, metabolism and obesity, and
cardiovascular endocrinology. They also used results from experimental and
epidemiological studies "to implicate EDs as a significant concern to public health"
[10].
EDs can be found in a variety of materials, including drugs, plant constituents,
pesticides, compounds used in the plastics industry, consumer products, and
other industrial by-products and pollutants [41]. Some are pervasive and widely
dispersed in the environment. Some are persistent organic pollutants (POP), and
can be transported long distances across national boundaries [11]. Food is a
major route by which people are exposed to EDs. Diet is thought to account for up
to

90%

of

a

person's

polychlorinated

biphenyls

(PCB)

and

dichlorodiphenyltrichloroethane (DDT) body burden [10]. With the increase in
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household products containing EDs, indoor air has also become a significant
source of exposure [12].
Xenoestrogens, a subset of EDs, are a diverse group of chemicals that bind
to the ER, mimic natural estrogen action, and interfere with normal endocrine
system function. Xenoestrogens, which can be produced naturally (e.g.
phytoestrogen) or synthetically (e. g. bisphenol A (BPA), DDT, etc.), are currently
the most studied EDs due to their various potential effects on human health.
Humans are exposed to xenoestrogens in their everyday life, from the food they
eat to the products they use, and their potential effects are very complicated.
Some xenoestrogens have been implicated in a variety of environmental health
problems, in both males and females, including disrupting the normal secretion of
hormones and disturbing the body's metabolism, which can have serious
consequences, including damage to reproductive functions [13]. DDT has been
reported to induce the feminization of gull embryos [14]. Another important
potential effect of some xenoestrogens is carcinogenesis, specifically in relation to
breast cancer. These xenoestrogens can mimic 17J3-estradiol by binding the ER
causing alterations to normal gene transcription and expression of ER and may
lead to the occurrence of breast cancer [15]. There is substantial evidence in a
variety of recent studies to indicate that estrogenic chemicals can increase breast
cancer cell line growth in tissue culture [16].

In clinical practice, hormone

replacement therapies have been related to increased cases of breast cancer
[17].
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In spite of the harmful effects, xenoestrogens also have been associated with
benefiting human health. For example soybean products, which are rich in
phytoestrogens including coumestrol, are common in the daily diets of East
Asians and are believed to be the reason that the incidence of breast cancer in
East Asian women is much lower than western women [18].
As far as the complicated potential effects of xenoestrogens, a better
understanding of xenoestrogens, their identification, and mechanisms of action is
of great significance. The United States Environmental Protection Agency (EPA)
has initiated a screening and testing strategy to determine whether exogenous
substances may have an effect in humans similar to those of natural hormones.
Eighty seven thousand chemicals were quoted by the EPA as potentially requiring
analysis for endocrine activity [19].
Traditional methods for estrogen determination are bioassays, such as the
competitive receptor binding assay, E-screen assay or uterotrophic assay. The
E-screen assay was developed to assess the estrogenicity of environmental
chemicals using the proliferative effect of estrogens on their target cells (MCF-7)
as an end point [39]. The uterotrophic assay is an in vivo assay for estrogenicity. It
is based on the principle that the growth phase of the uterus in the natural estrous
cycle is under the control of estrogen [40]. However, concern about the amount of
chemicals needed for the test, prohibits the timely and costly route of bioassay
analysis. Therefore, alternative approaches, such as structure activity relationship
(SAR) modeling, may overcome these problems and make it possible to screen a
large number of chemicals in a reasonable time.

4

SAR is a methodology to study the relationship between the chemical
structure of a molecule and its biological activity. The analysis by SAR may
identify the chemical groups responsible for producing a biological effect in an
organism. Therefore, SAR has become a powerful tool for screening and
mechanism of action analysis. SAR models can be built using chemicals with
similar or diverse structures that demonstrate similar toxic effects, which can then
be used as screening tools for compounds with unknown activities. Furthermore,
it may be possible to modify a compound's structure to determine which
substructure is associated with a specific biological activity. Medicinal chemists
use the techniques of chemical synthesis to insert new chemical groups into a
biomedical compound and test the biological effects of the modifications.
In comparison to bioassay studies, SAR modeling may be an efficient way to
screen xenoestrogens. Thousands of chemicals can be screened per day, making
it a very important alternative and complimentary technique for xenoestrogen
screening. By using SAR modeling, some structural alerts related to estrogenic
ligand binding have been discovered. However, this information is not complete
because the current structural alerts cannot explain the potency or the activity (i.e.,
from ER binding to high level health effects) of all the xenoestrogens. For example,
the aromatic ring is considered an important structural alert for estrogenicity.
However, not all aromatic compounds are estrogenic, including flavone and
catechin. Furthermore, aromatic estrogenic compounds have a wide range of
affinities for the ER. Some of these compounds are strong binders

(17~-estradiol),

while others are weak binders (BPA). Therefore, aromaticity alone cannot explain
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the activity of xenoestrogens. This project will use SAR modeling to build models
to screen xenoestrogens with regard to their potency and study the mechanisms
for receptor binding. We will also model several common subclasses of ER
mimics, such as biphenyl, steroid and phytoestrogen, to investigate the effect of
classes on predictivity. By doing so, we hope to get a better understanding of the
roles that the existing structural alerts play.
Some SAR models for the estrogen receptor ligands have been developed,
including qualitative and quantitative ((0) SAR) models. For example, the Multiple
Computer Automated Statistical Evaluation Expert System (MultiCASE) is a
semi-quantitative model, and has been recently employed for screening
chemicals with ER binding potential [20]. Gilles

et a/.

used the MultiCASE expert

system to do the SAR study on a diverse set of ER ligands. In their study,
substructural features associated with ER binding activity and features that
prevent receptor binding were identified [20]. The fundamental assumption of
MultiCASE is that the observed biological activity of a molecule is governed by
substructures called biophores. However, there are certain disadvantages of
using MultiCASE. For example, the false positives are not correctable, and
predictions may not be defensible and mayor may not reflect known mechanisms.
This is because MutiCASE is a black box system, and people cannot get into the
inside of a model to see the process of its predictions. For OSAR models, the
Comparative Molecular Field AnalysiS (CoMFA) is a widely used 3D OSAR
method in drug design, and has been widely used to develop models correlating
structural differences in molecules with their ability to compete for binding to the
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ER [21]. Wu et al. carried out a study on 3D QSAR of f1avonoids and ER based on
docking. In this study, they identified the structural features associated with
estrogenic activity by providing insight into the interaction between the ligands
and key amino acid residues in the binding pocket [43]. The basic assumption in
CoMFA is that a suitable sampling of static (van der Waals) and electrostatic fields
around a set of aligned molecules yields information necessary to explain their
biological activities. The disadvantage of CoMFA is that it requires structurally
similar compounds and their accurate alignment.

In summary, previous

xenoestrogen models lacked transparency, were not mechanistically sound, or
could not be used with a diverse groups of chemicals. The goal of this study is to
eliminate these deficiencies.
For this study, we used the cat-SAR expert system. The cat-SAR expert
system tries to compensate for some limitations of the existing modeling systems.
It is a computationally based SAR expert system that was originally developed to
associate 20 chemical fragments with active and inactive compounds in a
learning set. Unlike other 20 approaches including MultiCASE, cat-SAR is
transparent and does not include proprietary code. The approach is sharable and
allows unrestricted scrutiny, intervention, and optimization throughout the
modeling process. Unlike CoMFA, cat-SAR also does not require a congeneric set
of molecules, which makes it more applicable for diverse sets of compounds. The
previous studies on the MCF-7 cell proliferation model [22] and rat carcinogenesis
model [37] with cat-SAR produced validated results which demonstrate that
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cat-SAR is a reliable modeling method for identifying structural attributes
associated with xenoestrogens.
SAR modeling can also contribute to breast cancer prevention and therapy.
Currently, effective therapies exist to treat breast cancer, but there is a lack of
effective chemopreventative agents. SAR models can act as a screening tool to
differentiate the beneficial and harmful effects related to xenoestrogens. Modeling
of xenoestrogens may reduce breast cancer risks by allowing for quick
identification and understanding of their mechanisms of action. Therefore, SAR
can play a role in breast cancer prevention by either reducing the exposure of
carcinogenic xenoestrogens or broadening the use of anti-cancer xenoestrogens.
For breast cancer therapy, SAR may be helpful to facilitate the development of
novel anti-breast cancer medications by maximizing the drug's specific action on
the breast tissue but minimizing the toxic effect on other organ sites.
In this thesis, the cat-SAR expert system was used to model the NCTRER
database. Cat-SAR models for ER binding will be built based on this database.
The effects of ligand potency and chemical structure will be studied.
Xenoestrogen will be divided into several groups according to their relative
binding affinity (RBA) value and chemical classes, such as biphenyls,
diphenymethane, phytoestrogen, phenols, DES, and steroids. The relationship
between model accuracy and RBA value and chemical classes will be analyzed
based on the cat-SAR models. The model's performance and the structural
characteristics of these groups will be studied. Moreover, the fragments of
representative chemicals created by the cat-SAR models will be investigated.
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CHAPTER II
MATERIALS AND METHODS
The database

The NCTRER data was collected from the in vitro ER competitive-binding
assay, which provides quantitative assessment of a chemical's ability to bind to
the ER. The NCTRER database consists of 232 chemicals of which 131 are
ligands, 93 non-ligands and 8 marginally binding compounds. The compounds
were selected a priori based on structural characteristics and tested in a well
validated and standardized in vitro rat uterine cytosol ER competitive-runding
assay [23, 24]. This assay tested the IC5a of

17~-estradiol

and each potential

ligand. The relative binding affinity (RBA) values were calculated by dividing the
IC5a of

17~-estradiol

(17~-estradiol

by the IC5a of the competitor and multiplying by 100 ( RBA

IC5a! Competitor IC5a ) X

=

100). IC5a is a measure of the

effectiveness of a compound in inhibiting biological or biochemical function. This
quantitative measure indicates how much of a particular drug or other substance
(inhibitor) is needed to inhibit a given biological process (or component of a
process, i.e. an enzyme, cell, cell receptor or microorganism) by half. The
chemicals were divided into ligand or non-ligand by their RBA values. If the RBA
value is equal to 0, it is considered as non-ligand. If the RBA value is greater than
1x10-5 , it is considered as ligand. Otherwise it is a marginally binding compound.
The database is a structurally diverse set of natural, synthetic, and environmental
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estrogens covering most known estrogenic classes and spanning a wide range of
biological activity. It represents the largest published ER binding database of
same-assay results generated in a single laboratory [25]. NCTRER database was
downloaded from the EPA website. The structures of the 232 chemicals were
input into the sybylB.1 software [42] for the purpose of fragmentation, visualization
and record keeping.
Create activity file

The activity file is a crucial file in the modeling process because it is needed
for matrix building and all the validations. After the database was built, an activity
file was created according to the RBA value reported by the NCTRER database.
In the activity file, the ligand was defined as "1", and the non-ligand "0", and the
number "1" and "0" were listed in one column in the same order with the database
so that it can be input into the database directly. The activity file was saved as
a .txt file.
Learning set development

The cat-SAR models were built through a comparison of structural features
found amongst two designated categories of compounds in the model's learning
set: ligand (active) and non-ligand (inactive). The cat-SAR learning set consists of
the chemical name, its structure as a MOL2 file, and its categorical designation
(e.g. "1" for ligand and "0" for non-ligand). Typically, organic salts are included as
the freebase, simple mixtures and technical grade preparations are included as
the major or ligand component, and metals, metal organic compounds, polymers,
and mixtures of unknown composition are not included. In our study, we have
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developed three learning sets: marginal chemicals as ligands (M+), marginal
chemicals as non-ligands (M-) and marginal chemicals excluded (non-M).
In silico chemical fragmentation and the compound-fragment matrix

The Tripos SybylB.1 HQSAR module [26] was used to fragment the
chemicals in silica into all possible fragments meeting user-specified criteria. In
HQSAR, the attributes were selected for fragments determination such as atom
counts (i.e., the size of the fragments), bond types, atomic connections (i.e., the
arrangement of atoms in the fragment), explicit hydrogen atoms, chirality, and
hydrogen bond donor and acceptor groups. Fragments can be linear, branched,
or cyclic moieties. Models developed herein contained fragments between two
and seven atoms in size and considered atoms, bond types, and atomic
connections as well as the hydrogen atoms.
After fragmentation, a compound-fragment data matrix was produced with a
Sybyl HQSAR addon as a text file. In the matrix, the rows are intact chemicals and
columns are the molecular fragments. Thus for each chemical, a tabulation of all
its fragments are recorded across the table rows, and for each fragment all
chemicals

that

contain

it

are

tabulated

down

the

columns.

The

compound-fragment matrix is analyzed with the cat-SAR programs to identify
structural features associated with the categorized ligand and non-ligand
compounds.
Identifying important fragments

A measure of each fragment's association with biological activity was next
determined. To ascertain an association between each fragment and biological
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activity, a set of rules are parameterized to choose important ligand and
non-ligand fragments. The first selection rule is the "number rule" which is the
number of chemicals in the learning set that contains a fragment. The second rule
is the "proportion rule" which considers the percentage of ligand or non-ligand
compounds that possess each fragment. For example 4/0.9/0.85, the number 4
reflects the "number rule" which means the fragment must be found in at least 4
compounds. When the number rule is too small, it may risk inclusion of fragments
that do not relate to certain biological activity because a large amount of
fragments will be produced. On the other hand, the large value of this number
would increase the chance of missing important features based on the diverse
nature of the learning set. The numbers 0.9 and 0.85 are the "proportion rule", and
this means the fragment should be found in at least 90% of ligands or 85% of
non-ligands. The values of the "number rule" and "proportion rule" were estimated
by the cat-SAR Rule Optimization routine. The Rule Optimization routine in our
study allowed the "number rule" to range between 1 and 8 with increasing
intervals of 1 and the "proportion rule" to range between 0.50 and 0.95 with
increasing intervals of 0.05 [27]. We reasoned that even if a particular fragment is
associated with a ligand, there may yet be other reasons for the compound from
which it is derived to be classified as a ligand (e.g., other fragments or
chemicophysical properties), thus it would not be expected to be found in 100% of
the ligand. Likewise is true for fragments associated with non-ligand. Thus, if we
considered only those fragments found exclusively in ligand or non-ligand we
would rarify the fragments pool to an unreasonable level and risk losing valuable
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information. On the other hand, we expected that fragments found to be
presented approximately equal in the ligand and non-ligand fragment sets would
not be associated with biological activity. Such fragments may serve as structural
scaffolds holding the biologically features and are not directly related to activity or
inactivity. It should be noted that the cat-SAR program uses a weight-of-evidence
approach to select important fragments, rather than statistical analysis.
Predicting Activity

The resulting list of important fragments can be used to predict the activity of
an unknown compound (compound that we do not know its activity). The
approach compares the important fragments between learning sets and those in
the unknown compound. If they have no common important fragments, no
prediction of activity is made If there are common important fragments, cat-SAR
can make a prediction for the compound with uncertain activity according to the
percentage of activity of the common important fragments. The probability of
activity or inactivity is then calculated based on the total number of ligand and
non-ligand compounds containing the fragments.
To classify an unknown compound back to a ligand or non-ligand category,
rather than a probability of activity, the program identifies an optimal cut-off point
that is able to separate ligand from non-ligand based on the model validation
analysis [28]. The compound predicted with a value larger than the cut-off value is
considered to be a ligand; otherwise it is considered a non-ligand. The cut-off
point can be adjusted according to the best overall concordance or the balance of
sensitivity and specificity.
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Model validation
Both internal and external validations were conducted for each model. For
the internal validation, the leave-none-out (LNO), leave-one-out (LOO), and
leave-many-out (LMO) validations were used. For the LNO, a model was
developed from the complete learning set of 232 compounds and the model was
used to predict the activity of each compound in the learning set. For the LOO
validation, each chemical, one at a time, was removed from the model's learning
set. The remaining n-1 compounds were used to build a n-1 model. The activity of
the removed compound was then predicted by the n-1 model. Predicted vs.
experimental values for each chemical were then compared and concordance,
sensitivity, and specificity values were calculated. For the LMO validation,
randomly selected 10% of the chemicals were removed from the learning set.
Then the remaining compounds were used to develop the model. The activity of
each removed chemical was predicted by the n-10% model. Predicted vs.
experimental values for the removed chemicals were then compared, and the
n-10% model's concordance, sensitivity, and specificity were determined. This
was repeated 10,000 times and the average concordance, sensitivity, and
specificity values were calculated.
The results of the LNO, LOO and LMO were expressed by three values; they
are sensitivity, specificity and concordance. The equations for them are:
Sensitivity = Correct positive predictions/Total positive predictions; Specificity =
Correct negative predictions/Total negative perditions; Concordance
predictions/Total predictions.
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= Correct

For the external validation, ten random sets of 10% of the chemicals in the
learning set were removed, and the remaining 90% of the compounds were used
to develop a model. The model was then used to predict the activity of those left
out, and the average sensitivity, specificity, and concordance values of the 10
random sets were calculated. In contrast to the LMO, the external validation is
more independent because it does not use any information from the testing set.
However, the LMO validation uses information of the testing set to decide the
cutoff point and the percentage of activity.
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CHAPTER III
RESULTS AND DISCUSSION
Model summary

Together, three sets of cat-SAR models were derived from the NCTRER
dataset: M+, M- and non-M. The Rule Optimization process was used to seek the
best model based on the LOO validation. For M+, M- and non-M models, the best
model's parameters were 4/0.9/0.85, 3/0.85/0.85 and 3/0.910.9 (Table 1),
respectively. For the best models, they are not the models with the highest
concordance value. Actually, the highest concordance value for M+, M- and non-M
were 0.93, 0.92 and 0.89 respectively, and the parameters for them were
2/0.8/0.95, 8/0.9/0.85 and 5/0.9/0.95 respectively (Table 1). The reason was that
the model with the highest concordance value did not satisfy other requirements
for a best model such as the coverage, the balance between sensitivity and
specificity or the validation results of LNO or LMO.
For the M+ best model, 1,849 "important" fragments were created, among
which 909 were fragments associate with ligands, and 940 were fragments
associated with non-ligands. For M- model, 2,386 important fragments were used,
and 1,122 were fragments associated with ligand and 1,264 were non-ligand
related. For this best model, M+ has 535 fewer important fragments than M-. This
may be due to the parameter difference or the classification of the marginal
chemicals. To further study this question, the important fragment number for
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different parameters and classification of marginal chemicals were extracted
(Table 2). As shown in Table 2, the classification of marginal chemicals has very
little effect on the fragment number. When comparing M+ and M- models with the
same parameters there was a difference of only 65 fragments for 3/0.85/0.85 and
28 fragments for 4/0.910.85. But if the classification of the marginal chemicals is
the same, the change of parameters produces a bigger difference on fragment
number. For instance, 4/0.9/0.85 has 612 fewer fragments than 3/0.85/0.85 for M+
and 565 fewer for M-. This shows that the difference in parameters is the main
reason for the difference of important fragments. When the number rule increases
from 3 to 4, more fragments will be ruled out. It is the same for the proportion rule.
When it changes from 0.85/0.85 to 0.910.85, the number of qualified fragments will
decrease. Our experimental data reflect this rule.
In order to investigate the performance of the M+ and M- models on marginal
chemicals, the predictions of the eight marginal chemicals by the two sets were
analyzed. Table 3 shows the prediction of the eight marginal chemicals. For the

M+ model, three of them were correctly predicted as ligand, three were incorrectly
predicted as non-ligand, and two were unpredictable. For M- model, five of them
were correctly predicted as non-ligands, two of them were incorrectly predicted as
ligands, and one was unpredicted (Table 3). The M- model made more correct
predictions on marginal chemicals than M+ model. However, we can not conclude
which model is better because neither this difference because neither the
difference nor the sample size was big enough to make the conclusion.
LOO validation

17

LOa validation was performed before LNO and LMO validation because the
best models were selected based on LOa validation. For the best model of M+,
sensitivity, specificity and concordance values were 0.91, 0.74 and 0.85,
respectively (Table 4). For M-, the sensitivity, specificity and concordance values
were 0.90, 0.81 and 0.86, respectively. For non-M learning set, the sensitivity,
specificity and concordance values were 0.92, 0.76 and 0.86, respectively.
Comparing the LOa validation results of the best model of the three sets (M+, Mand non-M), the sensitivity and concordance values were very similar. This shows
that the marginal chemicals did not greatly affect the performance of the model.
Therefore, for the remainder of this study, we concentrated on the models from
the M+ and M- .
LNO validation

After the best models were selected based on LOa, LNO validations were
carried out using the parameters from the best models. Both M+ and M- models
produced the same concordance value of 0.92 (Table 4).

The sensitivity and

specificity values for the M+ were 0.96 and 0.84, while for the M- they were 0.97
and 0.86. For the LNO, the performances of the best model from the two sets
were very close to each other. LNO validation is also called self-fit validation. The
characteristic of this kind of validation is that the model is developed from the
whole learning set, and that model is used to predict the activity of each
compound in the learning set.
LMO validation

The LMO validation yields a concordance value of 0.84 for both M+ and M-
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models.

The sensitivity values were 0.90 and 0.89, and specificity 0.75 and 0.77

for M+ and M-, respectively (Table 4). The validation results of M+ and M- were very
close to each other. LMO is also a cross-validation. The vital aspect of this
validation is that more than one chemical was taken out every time from the
testing set. The selection of testing set was random. In this study, the process was
repeated for 10,000 times.
In summary the LNO, LOO and LMO are all internal validations. Comparing
the three values (sensitivity, specificity and concordance) of LNO, LOO and LMO,
all the values are in the same order: LNO > LOO > LMO. This trend is reasonable
because an increasing number of chemicals were removed from the learning set
from LNO to LMO validation. LNO did not have any chemical removed, LOO had
one removed each time, and LMO has 10% of the total chemicals removed each
time. With more chemicals removed, less information is available to develop a
model, and the difficulty of making a correct prediction increases. Therefore, it is
reasonable that the value of the LMO validation was lower than LNO and LOO. If
the results did not show this trend, for example, the LMO had better value than
LNO or LOO, this means that a systemic mistake may exist.

External validation

Table 4 also shows the results of the external validation analysis. The
average concordance values for M+ and M- are 0.82 and 0.80; the sensitivity
values were 0.81 and 0.90, and the specificity values were 0.83 and 0.69. The
concordance values were lower than the LMO validation concordance values.
According to the external validation, the M+ model is better than M- because it is
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more balanced and has a higher concordance value. For the external validation,
the testing set is more independent from the training set compared to LMO.
Therefore the results are more reliable. The values of sensitivity, specificity and
concordance of the external validation indicate that the NCTRER cat-SAR models
can identify the ER ligands.
The relationship of RBA and the prediction

To study the relationship of the model's LOa predicted values and the RBA
values, 232 compounds were divided into five groups according to their RBA
values. The range of the five groups was defined by the NCTRER database [26]
(Table 5). The slight binders (what we called marginal compounds) group
(O<RBA<1 E-5) had the lowest percentage of correct predictions with three out of
eight predictions being correct, which was followed by the non-ligand group in
which 80% had been predicted correctly. This was a relatively lower percentage of
correct predictions, especially when compared to the ligand compounds, which is
over 90%.

The weak, medium and strong ligand groups had similar percentages

of correct predictions with values of 94, 92, and 93%, respectively. To explore the
cause of this discrepancy, the structure of the compounds incorrectly predicted in
the lower percentage groups were investigated. There were 19 incorrectly
predicted compounds in the non-ligand group, and all of them had. an aromatic
ring and 11 (or 57%) of them contained a phenolic ring. For the slight binder, or
marginal group, all four compounds predicted incorrectly had aromatic rings and
none of them had a phenolic ring. As shown previously, the aromatic or phenolic
ring is an important biophore for estrogenicity and makes them very similar to
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ligand compounds that actively bind to the ER [23]. If a compound has an
aromatic or phenolic ring but is not estrogenic, this makes it more likely to be
incorrectly predicted as a ligand compound. Based on this analysis, it can also be
concluded that aromatic ring or phenolic ring are not sufficient to determine
estrogenicity because the non-ligands can also have them. There should be other
structures that contribute to the binding activity. On the other hand, this also
shows the predictions of our cat-SAR expert system were based on the structure
of the chemicals. This should be studied further in the future.

The relationship of different chemical classes and model prediction
To further study the relationship between prediction accuracy and the
chemical categories, the chemicals were sorted by their chemical categories
according to the NCTRER database classification. The uneven distribution of
correct predictions was found among different chemical categories for M+ and M-.
Table 6 shows the result for M+ and M-, where M- had similar results as M+. The
order for percentage of correct predictions is: biphenyls < diphenylmethane <
phytoestrogen < phenols < DES < steroids. According to the results, the biphenyls
group had the lowest percentage of correct predictions, and the steroid group had
the highest. One reason for the difference in correct predictions may be that the
sample size for biphenyls is too small. The group only has 12 chemicals in total,
and one is not predicted. Among the 11 predicted chemicals, four of them were
incorrectly predicted, and seven of them were correctly predicted. The small
sample size makes the results easier to be skewed. For other groups, the sample
size is much larger than the biphenyls. Another possible explanation for this
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group's low percentage of correct predictions is that the non-ligand chemicals in
this group all have aromatic ring. For biphenyls, there are three aromatic
non-ligands out of 12, and all of them are incorrectly predicted. But the steroids,
which have a high percentage of correct predictions, do not have any aromatic
non-ligands.

Actually the

non-ligand

aromatic chemicals decreased the

performance of the model because they have structural alerts similar to ligands
for the ER. This may lead the model to predict them as ligands. This agrees with
what was discovered by RBA classification on aromatic non-ligand chemicals.
Furthermore, according to the structure of biphenyls, they do not have a
hydrophobic center. This may also contribute to its low performance because
hydrophobic center is one of the important structures related to ER binding.
According to our investigation, all the good ER binders have an ideal hydrophobiC
center. The ideal hydrophobiC center means the proper size with enough
hydrophobicity. Therefore, the hydrophobicity can also be used to make a
prediction on binding activity. Comparison of compounds in the biphenyl group to
those in the diphenylmethane group demonstrates that they all have two aromatic
rings. The difference is that the diphenylmethane have a hydrophobic center, but
biphenyls do not. Diphenylmethanes also have non-ligand chemicals with
aromatic rings. There were nine such chemicals out of 28 chemicals compared to
biphenyls, which had three out of 12, and six of them were incorrectly predicted.
Although diphenylmethane compounds also have non-ligand chemicals with
aromatic ring, it has a higher percentage of correct prediction than biphenyls. This
is due to its hydrophobiC center which helped the cat-SAR expert system make a
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correct prediction on the ER ligands. The uneven performance on different
chemical classes shows that its prediction is based on the structure analysis, and
important fragments play a vital role in deciding a chemical's activity. It also
reminds us that having a bigger sample size and similar number of chemicals of
different chemical classes may improve the performance of the models.
Furthermore, making the application domain' more specific to a chemical class (Le.
biphenyls or steroids) may be a better way to improve the model's performance.
Moreover when these models are used to assess the ligand binding potential for a
new or untested chemical, it is likely that chemical class and the compound's true
potency will affect the reliability of the prediction.
Examples of cat-SAR predictions

In order to investigate model prediction for compounds, four chemicals of
different activity were chosen to demonstrate the process. They were
17~-estradiol,

coumestrol, BPA and progesterone whose RBA values were 100,

0.9, 0.008 and 0, respectively. They are representatives for the strong, medium
and weak ligands, and the non-ligand categories.
As demonstrated by the activity and fragment information of

17~-estradiol,

it

was correctly predicted as a ligand compound by M+ and M- (Table 7). Figure 1
shows the structure of

17~-estradiol

and some of the fragments created by two

sets. In order to perform the analysis, the fragments were divided into three
sections: section 1 specifically covered the 3-0H group and the affiliated aromatic
ring A, and section 2 covered the interior Band C rings, and section 3 specifically
covered the 17-0H group and the affiliated ring D.
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Fragments from section 1 identify the aromatic ring A and the affiliated 3-0H
group, which have been identified as two of the most important structural alerts for
17f3-estradiol [29]. It contributes about 1.5kcal/mol to the total binding energy,
which is 12kcallmol [30]. If the aromatic ring is replaced with other rings, the
binding affinity will decrease dramatically. For example, if 17f3-estradiol's aromatic
ring is replaced with cyclohexane, it becomes 3a-androstanediol (Table 8), and its
RBA value decreases to 0.002 [31]. In fact, 3a-androstanediol cannot be
predicted by either of our models. Due to its lack of an aromatic ring, its fragments
could not be found in the important fragments list of either model. In our study, all
the fragments of 17f3-estradiol contain part of the aromatic ring. All of this
information indicates that the model identified this structure and used it to make a
prediction on ligands or non-ligands.
To further study the effects of the aromatic ring on model predictions, the
non-aromatic chemicals were taken out to study independently. Among 232
compounds, there are 28 compounds that do not have an aromatic ring. For 28
non-aromatic compounds, five of them are ligands, and 23 are non-ligands. Both
models correctly predicted all 23 non-ligands, but for the five non-aromatic ligands,
three were incorrectly predicted, and two were not predicted in both models. Thus,
there were no correct predictions for the five non-aromatic ligands. This again
suggests that the aromatic ring is an important structure for ER binding, and the
model expert system uses it to make a correct prediction for ER ligands.
Section 1 also includes the structure 3-0H. The 3-0H group contributes
approximately 1.9kcal/mol of binding energy as a hydrogen bond donor [30]. It

24

forms a hydrogen bond with the Glu 353, Arg 394, and a water molecule [31,32].
When the 3-0H group is removed, the RBA value drops significantly when
comparing similar compounds (e.g. 3-deoxy-estradiol). In the fragment list of
17~-estradiol,

we found four fragments that contained the 3-0H group, and all of

them were mostly found in the fragment list of ligands. This shows that our models
can identify the 3-0H group as a structural alert for ER ligands.
The fragments from section 2 are derived from the hydrophobic center for
17~-estradiol

[30]. The ligand binding domain (LBO) of ER is a hydrophobic

pocket, which creates a favorable environment for binding ligands that possess a
hydrophobic center [33]. Another important aspect of section 2 in relation to
17~-estrodiol

is that it creates a favorable distance between the 3-0H and 17-OH

group. The distance between these two hydroxyl groups is do-c. It is a factor that
affects the binding affinity of a ligand [31]. Either too large or too small do-o is not
favorable for ER binding, and a certain range of do-o can make the binding more
stable.

For example, the do-ofor 17~-estrodiol is 11.0 A, which allows the 3-0H

and 17-0H to appropriately align with the ER binding pocket and form hydrogen
bonds, which creates a much stronger interaction between the receptor and the
ligand, thus increasing the binding affinity. The compounds that do not have a
steroidal backbone usually have very low RBA value, even though they have an
aromatic ring or a -OH group, such as the phenols, and biphenyls. The reason for
this is that the steroidal backbone offers the favorable conformation for ligand
binding [31]. This explains why the average RBA value of steroid compounds is
higher than biphenyls because the steroids have the hydrophobic center and the
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do-o value is similar to the natural estrogen.
In the fragment list, there are 253 fragments that cover this section. Among
the three sections, this section has the largest number of fragments because this
section also includes parts of the aromatic ring. There is no important fragment
that does not have any part of the aromatic ring. Therefore, we can conclude that
only the hydrophobic fragments are not enough for receptor binding. It has to be
coupled with an aromatic ring to form a ligand. This may explain why fragments of
section 2 all have some part of the aromatic ring.
The fragments from section 3 identify the 17-OH group, which contributes
about O.6kcal/mol as a hydrogen bond acceptor [29]. The 17-OH group can form
an H-bond with His 524 [31]. If the 17-Ot-{ group was removed, the RBA would
decrease. For example, the 17-deoxy-estradiol has a RBA value of 14.1 which is
seven times lower than 17f3-estradiol. Although 17-deoxy-estradiol does not have
the 17-0H group, it was correctly predicted as a ligand in our model (Table 8).
This suggests that 17-OH is important, but it is not imperative for activity. The M+
and M- models have the same fragment for section 3, which is a 17-OH group
affiliated with a four ring skeleton, and it is the only fragment found in this section.
These findings demonstrate that 17-OH is a structural alert for ER ligands, but by
itself is not enough to greatly affect ligand's binding ability to the ER. In fact, it
seems that 17-OH needs to be combined with hydrophobic fragments and
aromatic fragments to construct a complete ligand. Therefore, the 17-OH is not a
necessary structure for the ER ligand, but it is a structure that can increase the
binding affinity of a compound to the ER.
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Coumestrol is a phytoestrogen and another ER ligand in the learning set.
Coumestrol has three aromatic rings, two at the ends of the compound and one in
the middle. The chemical shape of coumestrol orients its two hydroxyl groups in
the same position as the two hydroxyl groups in 17p-estradiol, allowing it to mimic
the structure confirmation of 17p-estradiol. However, The RBA value for
coumestrol is 0.90, which is about 100 times lower than 17p-estradiol. It was
predicted as a ligand compound by M+ and M-. The M+ and M- models created
eight and ten fragments in total, respectively, and all of them described the phenol
ring. Five representative fragments from both sets are shown in Figure 2. From
the fragments of coumestrol, we found that all of the important fragments describe
the aromatic rings, either ring A or D. Comparison of coumestrol to 17p-estradiol
suggests that they have many similarities. They both have four rings and two -OH
groups at the A ring and D ring, which may explain why coumestrol binds to the
ER. However, coumestrol's RBA value is much lower than 17p-estradiol, which
means coumestrol is a relatively weaker binder compared to 17p-estradiol. This
may due to the fact that coumestrol's hydrophobic center is weaker than
17p-estradiol because it has three oxygen atoms, which makes it more hydrophilic
[34]. For the important fragments of coumestrol, none can represent the
hydrophobic center. This study shows the important fragments created by
cat-SAR were related to the ER binding activity.
Bisphenol A is used to make polycarbonate plastiC and epoxy resins, along
with other applications. There is concern that the wide daily use of it may be
related to some potential negative health effects [35-36]. It was predicted as a
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ligand by both M+ and M- models. The important fragments of BPA are shown in
Figure 3. These fragments describe three parts: the -OH group, the aromatic ring
and the bridge hydrocarbons. All of the fragments are related to the activity of BPA.
The bridge hydrocarbons act in a similar manner as the fragments from section 2
for 17j3-estrodial by forming a hydrophobic center. However, this center in BPA is
much smaller than in 17j3-estradiol. Therefore, the do-o of BPA is shorter than
17j3-estradiol, and may explain why BPA's RBA value is much smaller than
17j3-estradiol.
Progesterone, a vital hormone for pregnancy, is a non-ligand in both M+ and

M- learning sets and was correctly predicted by both models. In the M+ model, it
had 285 fragments in total, and 52 of them had an oxygen atom. All of the oxygen
atoms in those fragments were linked by a double bond, which prevents the
compound from forming a hydrogen bond with the ER. Also, this compound has
no aromatic rings. The lack of these structural features contributes to
progesterone's inactivity. Figure 4 shows some of the representative fragments of
progesterone and represents the differences in important fragments associated
with ligands and non-ligands.
From the above examples, we get a better understanding of what type of
fragments are most likely to construct a ligand or non-ligand compound. Therefore,
the cat-SAR expert system can not only make predictions for unknown
compounds, but also assist in the analysis of identifying the binding mechanism
and, therefore, potentially help in designing new compounds with specific
characteristics.
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CHAPTER IV
SUMMARY AND CONCLUSION
Overall, the present study demonstrated the utility of SAR modeling for
xenoestrogens screening and the ER binding mechanism study. The cat-SAR
expert system is a qualitative SAR, and its predictions are based on the activity of
the fragments derived from each chemical, and the predicted activity of each
compound is calculated by the frequency with which each fragment is found in
either ligands or non-ligands. Therefore, the learning set always consists of a
certain number of ligand and non-ligand chemicals as the NCTRER database
used in this study.
NCTRER is a unique database for analyzing xenoestrogens and ER binding,
since it contains a diverse set of chemicals with a wide range of binding affinities.
The database includes 232 compounds, of which 131 are ligands, 93 are
non-ligands and 8 are marginally binding chemicals. In total, 37 descriptors were
listed for each chemical, including their RBA value, their chemical class, and the
number of aromatic rings each chemical possesses, among others. In this study
these descriptors were used to understand how they affect ligand binding to the
ER. For example, the relationship of why different chemical classes bind to the ER
with varying degrees of RBA was analyzed.

Although the role of just a few

descriptors was investigated in this study, it is believed that the cat-SAR expert
system will be very useful in investigating the remainder of the descriptors
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found in the NCTRER database. Four different validation methods were used in
this investigation: LNO, LOO, LMO and external validation. The sensitivity,
specificity and concordance value were calculated for each of the validations. The
concordance values were all above 80%, meaning the cat-SAR methodology is
capable of making correct predictions for ER ligands.
The overall performance for the model was very good, but a discrepancy was
identified in the overall correct predictive rate among six different chemical
classes, including biphenyls, diphenylmethane, phytoestrogen, phenols, DES and
steroids.

For example, the percentage of correct predictions for biphenyls was

only 63%, but it was 93% for steroids, according to the M+ model. This indicates
that the closer a chemical's structure to the natural estrogen the higer possibility
of it being predicted correctly by the model. This also suggests that the models
have different predictive performances on different chemical classes (Le.,
chemical structure or potency). Therefore, when these models are used to assess
the ligand binding potential for a new or untested chemical, it is likely that
chemical class and the compounds true potency will affect the reliability of the
prediction.
Important fragments were identified by the cat-SAR expert system for each
chemical. The important fragments for the ligands covered most of the existing
biophores for ER binding such as the aromatic ring, 3-0H group, 17-OH group
and the hydrophobic center. But most of non-ligands do not contain the fragments
that were known as structures alerts related to ER binding. This shows the
cat-SAR expert system is mechanistically sound and can be used to carry out
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mechanism analysis in the future. Meanwhile, there are some fragments that can
not be explained by the exiting structural alerts; this offers the possibility of
discovering new biophores.
This study identified some important fragments for ER binding. However, it
is far from completed because we found some chemicals that do not have
structure alerts, but are ligands. For instance, we found that there are 25
chemicals with the phenolic ring but were non-ligands, and 14 of them were
correctly predicted by the M+ model. This demonstrates that there should be
other structures that define an estrogeniC chemical besides the phenolic ring.
Even when considering the phenolic ring, the location of the -OH group critically
affects the activity of the chemicals. These are examples of chemical structural
analysis that could be part of our future studies.
In conclusion, the NCTRER cat-SAR ER binding model is a reliable model for
xenoestrogen identification. The cat-SAR expert system identified important
fragments for ER binding that help explain why certain xenoestrogens bind to the
ER better than others. Therefore, this model can be used to do xenoestrogen
screening and potentially identify how well compounds will bind to the ER, strictly
based on their chemical structure. Furthermore, future studies may lead to the
discovery of other possible structural alerts for ER binding or estrogenicity.
Understanding these structural characteristics may lead to a better mechanism for
dealing with the carcinogenic and anti-carcinogenic properties associated with
these xenoestrogens. Making use of this model, or combining it with other models,
could explore this question in a meaningful direction.
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TABLES
Table 1. M+, M- and non-M Model comparison
2

O Cp 3

0.91

0.74

0.85

0.90

0.86

2/0.8/0.95

0.93

0.86

0.91

0.83

0.97

Best Model

3/0.85/0.85

0.90

0.81

0.86

0.86

0.91

Highest Ocp

8/0.910.85

0.92

0.91

0.92

0.92

0.61

Non-

Best Model

3/0.9/0.9

0.89

0.76

0.86

0.89

0.90

M

Highest Ocp

5/0.9/0.95

0.96

0.77

0.89

0.90

0.84

Parameters

Sen

Best Model

4/0.9/0.85

Highest Ocp

1

Spe

Cutoff Coverage

M+

M-

Note: 1. Sen is the abbreviation for Sensitivity.
2. Spe is the abbreviation for Specificity.
3. Ocp is the abbreviation for observed correction prediction, and equals to concordance
value.

The Sensitivity, Specificity and Concordance value is based on the LOO
validation.
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TABLES
Table 2. Fragments table

Model

Total

Ligand

Non-ligand

Fragments

Fragments

Fragments

Parameter

M+

3/0.85/0.85

2461

1214

1247

M-

3/0.85/0.85

2386

1122

1264

M+

4/0.901.85

1849

909

940

M-

4/0.910.85

1821

863

958

This table compares the number of fragments of the different classification of
marginal chemicals and parameters. Both the classification of marginal chemicals
and the parameter affect the number of fragments. M+ model has more fragments
than M- with the same parameter. For the same classification of marginal
chemicals, the fragments increase with the values of parameter increases. The
changing of parameter has more effects on fragments number than the
classification of the marginal chemicals.
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TABLES
Table 3. Marginal binding chemicals prediction.
CAS

M+

M-

117-81-7

incorrect

correct

2132-70-9

correct

correct

32598-13-3

unpredictable

incorrect

3424-82-6

correct

unpredictable

53-19-0

incorrect

correct

6554-98-9

correct

incorrect

85-68-7

incorrect

correct

90-00-6

unpredictable

correct

Eight marginal chemicals and their predicted results from M+ and M- were
listed.
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TABLES
Table 4. Validation summary for cat-SAR ER binding models
Validation
LNO

Model
M+

MLOO

M+

Mnon-M
LMO

M+

MExternal
validation

M+

M-

Sensitivity 1
0.96(121/126)
0.97(121/125)1

Specificity2
0.84(58/69)
0.86(73/85)

Concordance3
.92( 179/195)
0.92(194/210)

0.91 (115/127)
0.90(111/124)
0.92(113/123)

0.74(54/73)
0.81(70/87)
0.76(59/78)

0.85(169/200)
0.86(181/211)
0.86(172/201 )

0.90(10.0/11.1 )
0.89(10.5/11.8)

0.75(5.0/6.7)
0.77(6.3/8.2)

0.84(15.0/17.8)
0.84(16.8/20.0)

0.81(107/132)
0.90(106/120)

0.83(63/76)
0.69(64/92)

0.82(170/208)
0.80(170/212)

o

Notes: 1. Number of correct positive predictions I total number of positives;
2. Number of correct negative predictions I total number of negatives;
3. Observed Correct Predictions: number of correct predictions I total number of predictions

The table shows the validation results for LNO, LOO, LMO and external
validation for M+ and M - models, and also the LOO for the Non-M model.
Sensitivity, specificity and concordance values were calculated and listed in the
table. For LMO, the number of chemicals in parentheSiS is the average of 10%
removed chemicals.
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TABLES
Table 5. Distribution of incorrect predictions for M+ model

Compounds group
Non-ligand
(RBA=O)
Slight binder
(0<RBA::;1 E-5)
weak Ligand
(1 E-5<RBA::;0.01)
medium Ligand
(0.01 <RBA::;1)
strong Ligand
(RBA>1)

Total
compounds
number

Unpredictable
compounds
number

93

M+
Number of
correct
predictions

Percentage
of correct
predictions

0

74

80%

8

2

3

50%

61

9

49

94%

41

1

37

92%

29

0

27

93%

The compounds were divided into five groups according to their RBA value.
The number of correct predictions and percentage of correct perditions were
calculated.
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TABLES
Table 6. Prediction on different chemical classes
Ligands

Number of

Number of Correct

Percentage of

Categories

Compound 1

Prediction

correct Predictions

Biphenyls

11

7

63%

Diphenymethane

28

21

75%

Phytoestrogen

44

35

80%

Phenols

27

24

89%

DES

22

20

91%

Steroids

29

27

93%

Notes: 1. Number of compound does not include the unpredicted compounds.

This table shows the performance of cat-SAR ER binding model of M+ on
different chemical classes. The number and percentage of correct predictions
were calculated.
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TABLES
Table 7. Activity and fragment information for 17f3-estradiol
Predicted
Experimental

Fragments
percentage of

Model
activity

number
activity

M+ (4/0.9/0.85)

ligand

97%

258

M- (3/0.85/0.85)

ligand

95%

281

The activity and fragment information for 17f3-estradiol in both models.
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TABLES
Table 8. Structure and activity comparison for steroids

H

Structure

RBA

Predicted activity

#

0.002

Unpredictable

0.5

Ligand

14.1

Ligand

oY5 roB"
m±>
HO

3a ·androstanediol

HO

.0

17(3-estradiol

I~
Q

3·Deoxy·estradiol

RBA=100

HO

Q

17-Deoxy -estradiol

The effects of 3-0H, 17-OH group and aromatic ring on RBA value were
shown. The predictions of these three chemicals were also listed. The aromatic
ring has the biggest effect on activity then is the 3-0H group, then the 17-0H
group.
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2242
J4/38
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Section 3
4018
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''I
I
I

Figure 1. Important fragments of 17p-estradiol. All the important fragments
can be divided into three sections. Each section represents certain part of the
chemical.

40

FIGURES

OH

HO

M-

M+
1671
100/111
0.90

Key:
Frag Number
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1671
99/111
0.89

HO

4836
6/6
l.OO

HO

414
108/127
0.85

HO

XO
4848
6/6
1.00

4836
6/6
l.OO

XO

4848
6/6
1.00

XO

XO
4845
6/6
1.00

HO
4844
6/6
1.00

4844
6/6
1.00

HO

Figure 2 Fragments of coumestrol

Figure 2. Important fragments of coumestrol. All the important fragments
contains part of an aromatic ring and a -OH group.
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0.86 XO

Section B
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I
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34/35
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3731
34/36
0.94

3733
32/34
0.94

3782
32/34
0.94

3745
34/36
0.94

4358
3/3
1.00

Figure 3 Fragments of bisphenol A

Figure 3. Important fragments of bisphenol A. The fragments were divided
into two parts: section A and section B. Section A is the phenolic ring, and section
B is the aromatic ring and the hydrophobic center.
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Figure 4 Fragments of progesterone

Figure 4. Important fragments of progesterone. The percentage of activity of
the fragments was "0". No fragment that related to any biophores for ER binding
was found in the fragment list.
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APPENDIX
List of Abbreviations
NCTRER

National Center for Toxicological Research Estrogen Receptor

RBA

Relative Binding Affinity

ER

Estrogen Receptor

MultiCASE

Multiple Computer Automated Statistical Evaluation Expert
System

QSAR

Quantitative Structure Activity Relationship

SAR

Structure Activity Relationship

Cat-SAR

Categorical- Structure Activity Relationship

CoM FA

Comparative Molecular Field Analysis

GPCR

G Protein-Coupled Receptor

ED

Endocrine Disruptor

PCB

Polychlorinated Biphenyls

DDT

Dichlorodiphenyltrichloroethane

BPA

BisphenolA

LNO

Leave-none-out

LOO

Leave-one-out

LMO

Leave-many-out
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